Search Results for "Pfc Pharma Focus Switzerland"
Original Source: PFC Pharma Focus AG
1992 Foundation of PFC Pharma Focus Consultants, Ltd. privately owned, in Volketswil / Zurich Switzerland 1997 Alliance with the biometric institute BIOP in Basel, Switzerland 1999 Expansion to Germany with the foundation of PFC Pharma Focus GmbH in Munich 1999 Alliance with PharmaResearch Corporation, USA and UK 2002 Partnership with SocraTec R&D, Frankfurt, Germany 2005 Partnership or Regional Offices in...
Matching Channels
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
Visual acuity (VA) is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. Visu...
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...
Angiogenesis is the growth of new blood vessels. In cancer, it is one of the defining properties of tumour cells. A blood supply is critical for the tumour to survive, so anti-angiogenic drugs are t...
Self-management is quite a new idea in healthcare, and it is for patient with long-term conditions to regain some control over their life, and to be able lead a better life, despite their heal...
Matching News
ZUG, Switzerland, April 4, 2013 /PRNewswire/ --Covis Pharma Sarl ("Covis Pharma"), a Switzerland-based specialty pharmaceutical company today announced an agreement with sanofi-aventis U.S. LLC an...
Drugs in Search of a Disease-Men s Edition
Got Low T? In one sense, it is refreshing to see men being the target of pharma, after all these years of women being the focus of relentless and misleading advertising. On the other, we re seeing the...
Pharma Sales - Time to Include Your Customers!
Précis: With the advent of CLM comes an opportunity for change, from Pharma Sales to Pharma Services, however the key lies in client engagement....
Roche restructuring early R&D division
Roche (SIX:ROG; OTCQX:RHHBY) is closing its R&D site in Nutley, N.J., and cutting about 1,000 positions as part of a restructuring of its Pharma Research and Early Development division. The site's act...
ZUG, Switzerland, April 4, 2013 /PRNewswire/ -- Covis Pharma Sarl ("Covis Pharma"), a Switzerland-based specialty pharmaceutical company today announced an agreement with sanofi-aventis U...
Vifor good for Q4 filing, but can it vie for market?
Vifor Pharma and Fresenius Medical Care Renal Pharma (a Galenica/Fresenius joint Venture) are planning regulatory filings for their hyperphosphataemia drug PA21 in the US, EU and Switzerland, startin...
Forum to Discuss Evolving Pharma Regulations, Markets and Technology
It has become extremely crucial for Chinese pharma companies to truly understand where inspectors' focus are and get insights from other site inspection cases to increase market acceptance of their ph...
As our digital focus continues, Andy Stafford explores the world of pharma and healthcare gamification, looking at the benefits these apps have for patients. Okay, so what do I mean by gamifying phar...
Matching PubMed Articles
Analytical chemistry no longer neglected but gaps remain.
New Insights on the Mechanism of PPAR-targeted Drugs.
Industry perspective on palatability testing in children-Two case studies.
Circadian rhythms. A new histone code for clocks?
Allosteric modulators of the calcium-sensing receptor: turning news into distinct views.
